Skip to content
Twitter page opens in new windowMail page opens in new window
MoneyInvestExpert.com
Helping You Make The Most Of Your Money – Invest Smarter with Dividend
MoneyInvestExpert.comMoneyInvestExpert.com
  • Home
  • The 2023 Dividend Aristocrats
    • Dividend Aristocrats yearly performance
    • Dividend Aristocrats Dashboard
    • Dividend Aristocrats List 2023
    • Canadian Dividend Aristocrats
    • European Dividend Aristocrats
    • Defensive Aristocrats
    • Recession-Proof Dividend Aristocrats
  • Dividend Stock Lists
    • Top IPOs to Buy in 2022
    • Top Picks: 10 Stocks to Buy for 2022
  • Stock Portfolios
    • International Dividend Portfolio
    • Retirement Portfolio Dividend US
    • Bill Gates’ Stock Portfolio
    • Berkshire Hathaway Portfolio
    • Dogs of the Dow Tracker
    • European Dogs of the Dow Tracker
  • Home
  • The 2023 Dividend Aristocrats
    • Dividend Aristocrats yearly performance
    • Dividend Aristocrats Dashboard
    • Dividend Aristocrats List 2023
    • Canadian Dividend Aristocrats
    • European Dividend Aristocrats
    • Defensive Aristocrats
    • Recession-Proof Dividend Aristocrats
  • Dividend Stock Lists
    • Top IPOs to Buy in 2022
    • Top Picks: 10 Stocks to Buy for 2022
  • Stock Portfolios
    • International Dividend Portfolio
    • Retirement Portfolio Dividend US
    • Bill Gates’ Stock Portfolio
    • Berkshire Hathaway Portfolio
    • Dogs of the Dow Tracker
    • European Dogs of the Dow Tracker

Daily Archives: April 16, 2020

You are here:
  1. Home
  2. 2020
  3. April
  4. 16

Wall street

Goldman: The rally in markets has come “too far, too fast”

NewsBy dividend_investorApril 16, 2020

Goldman strategist Peter Oppenheimer says market rally has been too rapid. He warned that the rally in equities has probably gone “too far too fast”, as economies and corporate earnings will struggle due to the disruption caused by the coronavirus. “We would argue this rally is probably too far, too fast and there are still…

logo-abt

Abbott suspends 2020 guidance but keeps dividend

dividend-aristocrats, NewsBy dividend_investorApril 16, 2020

US healthcare company and dividend aristocrat Abbott Laboratories (ABT) announced its quarterly earnings of $0.65 per share, beating the estimated $0.58 per share. Net sales rose 2.5% to $7.73 billion, above the average estimate of $7.34 billion. Abbott Laboratories has suspended its 2020 guidance but maintained its quarterly dividend as the corona pandemic has an…

www.moneyinvestexpert.com Copyright 2011-2023 DISCLAIMER
Go to Top